BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients (Q44969666)

7 December 2017

title

BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients (English)

1 reference

7 December 2017

0 references

1 reference

7

1 reference

7 December 2017

Sarantaus L

1

1 reference

7 December 2017

Vahteristo P

2

1 reference

7 December 2017

Bloom E

3

1 reference

7 December 2017

Tamminen A

4

1 reference

7 December 2017

Unkila-Kallio L

5

1 reference

7 December 2017

Butzow R

6

1 reference

7 December 2017

publication date

1 June 2001

1 reference

European Journal of Human Genetics

7 December 2017

published in

1 reference

7 December 2017

volume

9

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

424-430

1 reference

Unusual case of Smith-Lemli-Opitz syndrome "type II"

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Breast cancer genes--what are the real risks?

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Contribution of BRCA1 mutations to ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Germline BRCA1 alterations in a population-based series of ovarian cancer cases

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Evidence of founder mutations in Finnish BRCA1 and BRCA2 families

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Rapid detection of BRCA1 mutations by the protein truncation test

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Genetics in clinical cancer care--the future is now

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Clues to the pathogenesis of familial colorectal cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4

1 reference

https://api.crossref.org/works/10.1038/SJ.EJHG.5200652

7 January 2021

Identifiers

DOI

10.1038/SJ.EJHG.5200652

1 reference

Dimensions Publication ID

7 December 2017

1027122338

0 references

1 reference